STOCK TITAN

Equity grant: Doximity (NYSE: DOCS) gives 21,314 RSUs to director

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Benjamin Regina M. reported acquisition or exercise transactions in this Form 4 filing.

Doximity, Inc. reported that director Benjamin Regina M. received a grant of 21,314 restricted stock units of Class A common stock on July 13, 2026 under the 2021 Stock Option and Incentive Plan at $0.0000 per share. 2,676 RSUs vest on November 15, 2026, with the remainder vesting in six equal quarterly installments through May 15, 2028, subject to continued service. Following the award, his direct Class A holdings total 50,903 shares.

Positive

  • None.

Negative

  • None.
Insider Benjamin Regina M.
Role Director
Type Security Shares Price Value
Grant/Award Class A Common Stock 21,314 $0.00 --
Holdings After Transaction: Class A Common Stock — 50,903 shares (Direct)
Footnotes (1)
  1. [object Object]
RSUs granted 21,314 shares Restricted stock units of Class A common stock granted on July 13, 2026
Initial vesting tranche 2,676 RSUs RSUs vesting on November 15, 2026, subject to continued service
Vesting installments 6 installments Remaining RSUs vest in six equal quarterly installments through May 15, 2028
Total direct holdings after grant 50,903 shares Class A common stock held directly following the RSU award
Grant price per share $0.0000 per share Stated transaction price for the RSU equity award
restricted stock units (each, an "RSU") financial
"These shares represent restricted stock units (each, an "RSU") granted on July 13, 2026"
2021 Stock Option and Incentive Plan financial
"granted on July 13, 2026 pursuant to the Doximity, Inc. 2021 Stock Option and Incentive Plan"
contingent right financial
"Each RSU represents a contingent right to receive one share of the Issuer's Class A"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Doximity (DOCS) report for Benjamin Regina M.?

Doximity reported that director Benjamin Regina M. received a grant of 21,314 restricted stock units (RSUs) of Class A common stock on July 13, 2026, as compensation under the company’s 2021 Stock Option and Incentive Plan, at a stated price of $0.0000 per share.

How do the 21,314 RSUs granted to Benjamin Regina M. at Doximity (DOCS) vest?

Of the 21,314 RSUs granted, 2,676 vest on November 15, 2026. The remaining units then vest in six equal quarterly installments through May 15, 2028, and each vesting tranche is conditioned on his continued service to Doximity.

What does each RSU granted to Benjamin Regina M. by Doximity (DOCS) represent?

Each RSU granted to Benjamin Regina M. represents a contingent right to receive one share of Doximity’s Class A common stock. Shares are delivered only as the RSUs vest over time, assuming he continues to provide service to the company.

What are Benjamin Regina M.’s Doximity (DOCS) Class A holdings after this RSU grant?

After the 21,314 RSU grant, Benjamin Regina M.’s reported direct holdings in Doximity Class A common stock total 50,903 shares. This figure reflects his position immediately following the award described in the insider ownership report.

Under which plan were the RSUs granted to Doximity (DOCS) director Benjamin Regina M.?

The 21,314 RSUs granted to Benjamin Regina M. were issued under the Doximity, Inc. 2021 Stock Option and Incentive Plan, which governs equity-based compensation such as restricted stock units awarded to eligible participants, including directors.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Benjamin Regina M.

(Last)(First)(Middle)
C/O DOXIMITY, INC.
500 THIRD STREET

(Street)
SAN FRANCISCO CALIFORNIA 94107

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Doximity, Inc. [ DOCS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock07/13/2026A21,314(1)A$050,903D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These shares represent restricted stock units (each, an "RSU") granted on July 13, 2026 pursuant to the Doximity, Inc. 2021 Stock Option and Incentive Plan, of which 2,676 RSUs shall vest on November 15, 2026 and thereafter the remainder shall vest in 6 equal quarterly installments through May 15, 2028, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.
Remarks:
/s/ John Vaughan, Attorney-in-Fact07/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)